Inhibition of corneal neovascularization by genetic ablation of CCR2

Cornea

Volumn 22, Issue 5, 2003, Pages 465-467

  Ambati, Balamurali K ^a,b   Joussen, Antonia M ^b,c   Kuziel, William A ^d   Adamis, Anthony P ^b,e   Ambati, Jayakrishna ^b,f  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e Eyetech Research Center   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Angiogenesis; CCR2; Cornea; Inhibition; Neovascularization

Indexed keywords

CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; DISEASE MODEL; GENOTYPE; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CORNEA; GENE DELETION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CHEMOKINE;

EID: 0037974689     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200307000-00013     Document Type: Article

References (32)

1. Epstein RJ, Stulting RD, Hendricks RL, et al. Corneal neovascularization. Cornea. 1987;6:250-257.
2. Kenyon BM, Voest EE, Chen CC, et al. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632.
3. Amano S, Rohan R, Kuroki M, et al. Requirement for VEGF in wound-and inflammation-induced neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
4. Kim CH, Broxmeyer HE. Chemokines: signal lamps for trafficking, development, and function. J Leukocyte Biol. 1999;65:6-15.
5. Yoshimura T, Yuhki N, Moore SK, et al. Human MCP-1. FEBS Lett. 1989;244:487-493.
6. Sato N, Ahuja SK, Quinones M, et al. CCR2 is required for Langerhans cell migration. J Exp Med. 2000;192:205-218.
7. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
8. Lindner V, Majacek RA, Reidy MR. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 1990;85:2004-2008.
9. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
10. Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1. Blood. 2000;96:34-40.
11. Berger O, Gan X, Gujuluva C, et al. CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med. 1999;5:795-805.
12. Moromizato Y, Stechschulte S, Miyamoto K, et al. CD-18 and ICAM-1 dependent corneal neovascularization and inflammation after limbal injury. Am J Pathol. 2000;157:1277-1281.
13. Philipp W, Speicher L, Humpel C. Expression of VEGF and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2513-2522.
14. Goede V, Brogelli L, Ziche M, et al. Induction of inflammatory angiogenesis by MCP-1. Int J Cancer. 1999;82:765-770.
15. Arras M, Ito WD, Scholz D, et al. Monocyte activation in angiogenesis and collateral growth. J Clin Invest. 1998;101:40-50.
16. Ito WD, Arras M, Winkler B, et al. MCP-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
17. Hayes IM, Jorda NJ, Towers S, et al. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thomb Vasc Biol. 1998;18:397-403.
18. Weber KSC, Nelson PJ, Grone HJ, et al. Expression of CCR2 by endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:2085-2093.
19. Nakashima E, Mukaida N, Kubota Y, et al. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharm Res. 1995;12:1598-1604.
20. Kuziel WA, Morgan SJ, Dawson TC, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA. 1997;94:12053-12058.
21. Kuziel WA, Maeda N. CCR2 and CCR5. In: Mak TW, ed. The Gene Knockout FactsBook, London: Academic Press, 1988:118-121.
22. Proia AD, Chandler DB, Haynes WL, et al. Quantitation of corneal neovascularization using computerized image analysis. Lab Invest. 1988;58:473-479.
23. Goede V, Schmidt T, Kimmina S, et al. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest. 1998;78:1385-1394.
24. Lin MT, Chen YL. Effect of copper ion on collagenase release: implication in corneal neovascularization. Invest Ophthalmol Vis Sci. 1992;33:558-563.
25. Ding Z, He Y, Wei H. A morphologic study of experimental corneal neovascularization. Chung Hua Yean Ko Tsa Chih. 1995;31:49-51.
26. Sonoda K, Sakamoto T, Yoshikawa H, et al. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors. Invest Ophthalmol Vis Sci. 1998;39:2245-2251.
27. Van der Veen G, Broersma L, Dijkstra CD, et al. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest Ophthalmol Vis Sci. 1994;35:3505-3515.
28. Ambati BK, Anand A, Joussen AM, et al. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci. 2003;44:590-593.
29. Kaufman A, Salentin R, Gemsa D, et al. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1alpha during differentiation of human monocytes to macrophages. J Leukocyte Biol. 2001;69:248-252.
30. Fantuzzi L, Borghi P, Ciolli V, et al. Loss of CCR2 expression and functional response to MCP-1 during the differentiation of human monocytes. Blood. 1999;94:875-883.
31. Tumpey TM, Cheng H, Cook DN, et al. Absence of MIP-1alpha prevents the development of blinding HSV keratitis. J Virol. 1998;72:3705-3710.
32. Klotz O, Park JK, Pleyer U, et al. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat. Graefes Arch Clin Exp Ophthalmol. 2000;238:88-93.